Discontinued — last reported Q3 '22
Humana Group and Specialty — Benefits Losses And Expenses increased by 1.3% to $1.50B in Q3 2022 compared to the prior quarter. Year-over-year, this metric declined by 12.8%, from $1.72B to $1.50B. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to premiums suggests rising medical costs or deteriorating underwriting performance, while a decrease indicates improved cost control or favorable claims experience.
This metric represents the total costs incurred by the Group and Specialty segment related to medical claims, pharmacy b...
Standard across health insurers as 'Medical Loss Ratio' components or 'Benefit Expenses' by segment.
hum_segment_group_and_specialty_benefits_losses_and_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|---|
| Value | $1.68B | $1.72B | $1.76B | $1.48B | $1.48B | $1.50B |
| QoQ Change | — | +2.7% | +2.1% | -15.8% | +0.1% | +1.3% |
| YoY Change | — | — | — | — | -11.6% | -12.8% |